Adapting to Change: API Custom Development and Manufacturing

Case study
Drug substance

Cambrex was approached by a top 100 European-based pharmaceutical company looking for a development and manufacturing partner to assist with an in-licensed product originating from an emerging pharma company. The molecule was in clinical Phase II / III trials and the customer required development work and scale-up to commercial manufacturing. The chemistry required was particularly challenging, and Cambrex needed to upgrade its commercial manufacturing assets prior to project initiation within 4 months. Cambrex was selected to assist with the project as we had an existing relationship with the originator company, extensive experience with the chemistry and process, and the necessary scale-up and commercial production expertise.

Read the full case study to learn how Cambrex was able to meet the client’s aggressive timeline and flexibility requirements.